IP Library Granted Patent US 7,585,523
Granted Patent B2
US 7,585,523 · App. 10/228,765 · Granted Sep 8, 2009

Composition and method to augment and sustain neurotransmitter production

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,585,523
App. No.
10/228,765
Granted
Sep 8, 2009
Kind
B2
Abstract

A method and composition to enhance the synthesis and release of the neurotransmitters by the oral administration of neurotransmitter precursors, along with natural plant substances that stimulate uptake of the neurotransmitters precursors, while adding natural plant substances that activate adenylate cyclase in order to avoid attenuation and prevent pharmacologic tolerance. The compositions for medical foods are designed to improve cognitive function, induced sleep, improve Parasympathetic function, improve autonomic balance, increase nitric oxide production, reduce blood pressure, increase blood flow, and treat virus infections. The compositions include amino acids such as choline, herbs such ginkgo biloba, and other foods such as cocoa. The method uses physiologic tests such as 24 hour ECG monitoring to create the appropriate combinations and assess the useful proportions.

Claims (2)

1. A method for enhancing acetyleholine neurotransmitter activity, comprising: orally administering a composition to a subject in need thereof, said composition comprising at least one component selected from the group consisting of choline and acetylcarnitine in the range of from about 20 mg to about 100 mg; at least one component selected from the group consisting of ginkgo biloba, ginseng, cinnamon, nutmeg, and St. John's Wort in the range of from about 1 mg to about 200 mg; at least one component selected from the group consisting of cocoa, caffeine, and theobromine in the range of from about 1 mg to about 200 mg; at least one component selected from the group consisting of neuroexcitatory amino acids, glutamate, glutamic acid, and glutamine in the range of from about 1 mg to about 200 mg; and hawthorn berry in the range of from about 1 mg to about 200 mg.

2. The method for enhancing acetylcholine neurotransmitter activity of claim 1 , wherein said composition is in a form selected from the group consisting of capsules, suspension caplets, chewable wafers, tablets, and powders.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2010
From: SHELL, WILLIAM E; CHARUVASTRA, ELIZABETH H
To: TARGETED MEDICAL PHARMA, INC.
Reel/Frame 025126/0722 →